OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments
Sebastian Schneeweiß, Elisabetta Patorno
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 658-690
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Edouard L. Fu
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 8, pp. 1305-1314
Open Access | Times Cited: 49

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Wajd Alkabbani, Karine Suissa, KRISTINE D. GU, et al.
BMJ (2024), pp. e080340-e080340
Closed Access | Times Cited: 17

Emulating a Randomised Controlled Trial With Observational Data: An Introduction to the Target Trial Framework
Stan Kutcher, James M. Brophy, Hailey R. Banack, et al.
Canadian Journal of Cardiology (2021) Vol. 37, Iss. 9, pp. 1365-1377
Closed Access | Times Cited: 45

Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework
Rishi Desai, Michael E. Matheny, Kevin B. Johnson, et al.
npj Digital Medicine (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 45

Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
Edouard L. Fu, Elvira D’Andrea, Deborah J. Wexler, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 5, pp. 592-601
Open Access | Times Cited: 18

Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes
Edward W. Gregg, Elisabetta Patorno, Andrew J. Karter, et al.
Diabetes Care (2023) Vol. 46, Iss. 7, pp. 1316-1326
Open Access | Times Cited: 13

Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
Vijay R. Varma, Rishi Desai, Sheeja Navakkode, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1312-1326
Open Access | Times Cited: 22

Observational designs for real-world evidence studies
Santosh Ramesh Taur
Perspectives in Clinical Research (2022) Vol. 13, Iss. 1, pp. 12-16
Open Access | Times Cited: 21

GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes
Tao Huang, Alessandro Bosi, Anne‐Laure Faucon, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 10, pp. 1195-1195
Closed Access | Times Cited: 4

Initiation of Psychotropic Drugs in Spouses of Patients With Early‐Onset Alzheimer's Disease: A Matched Cohort Study
Toshiki Fukasawa, Kiyoshi MATSUMOTO, Kotaro Sasaki, et al.
International Journal of Geriatric Psychiatry (2025) Vol. 40, Iss. 1
Closed Access

Author response to: OSIN-D-24–01586, “Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular risk”
Soichiro Masuda, Toshiki Fukasawa, Shuichi Matsuda, et al.
Osteoporosis International (2025) Vol. 36, Iss. 3, pp. 565-567
Closed Access

Step-by-step causal analysis of EHRs to ground decision-making
Matthieu Doutreligne, Tristan Struja, J. Abecassis, et al.
PLOS Digital Health (2025) Vol. 4, Iss. 2, pp. e0000721-e0000721
Open Access

Synthetic Data in Healthcare and Drug Development: Definitions, Regulatory Frameworks, Issues
Giuseppe Pasculli, Marco Virgolin, Puja Myles, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access

The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes
COLLEEN GAREY, Mark A. Clements, Alicia H. McAuliffe‐Fogarty, et al.
Pediatric Diabetes (2021) Vol. 23, Iss. 2, pp. 248-257
Open Access | Times Cited: 24

Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey
Guowei Li, Jingyi Zhang, Harriette G.C. Van Spall, et al.
Diabetologia (2022) Vol. 65, Iss. 9, pp. 1461-1472
Open Access | Times Cited: 16

Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes
Sara Yi Ling Folk, Janet Zappe, Kathleen Wyne, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 3

Zoledronic acid for hip fracture during initial hospitalization
WuQiang Fan, Xiaoxu Sun, Benjamin Z. Leder, et al.
Journal of Bone and Mineral Research (2024)
Closed Access | Times Cited: 3

FOUNTAIN: a modular research platform for integrated real-world evidence generation
Nikolaus G. Oberprieler, Manel Pladevall, Catherine B. Johannes, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Real world data and data science in medical research: present and future
Kanae Togo, Naohiro Yonemoto
Japanese Journal of Statistics and Data Science (2022) Vol. 5, Iss. 2, pp. 769-781
Open Access | Times Cited: 14

Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data
Yoshiya Tanaka, Shinichi Tanaka, Toshiki Fukasawa, et al.
Joint Bone Spine (2023) Vol. 91, Iss. 3, pp. 105680-105680
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top